Interactions of Peptide Amphiphiles With Viruses and Cells Are Enabled by Amorphous Nanostructures

Jean Roche, Lena Rauch‐Wirth, L Zimmerman, Fabian Zech, Jan Münch, Clarissa Read, Kübra KaygisizJournal of Peptide Science 2025 · DOI

TL;DR

This paper reveals that amorphous nanostructures formed by unsaturated peptide amphiphiles (PAs) are crucial for enhancing viral entry into cells, a mechanism distinct from previously studied fibrillar PAs. By enabling direct binding of virus-like particles (VLPs) to the cell membrane, these amorphous structures offer a promising avenue for developing more effective and biodegradable gene therapy vectors.

What Problem Does This Paper Address?

Gene therapy and other applications often rely on viral vectors to deliver genetic material into cells. However, a significant hurdle is the inefficient attachment of these viruses to the target cell membrane, which is often hindered by electrostatic repulsion between the negatively charged viral and cell surfaces. While self-assembling peptide amphiphiles (PAs) have emerged as promising "transduction enhancers" to overcome this, most research has focused on those forming ordered, fibrillar structures. These fibrillar PAs work by reducing electrostatic repulsion and engaging cellular protrusions. However, the precise mechanism by which other types of PAs, particularly those derived from unsaturated fatty acids, achieve enhanced viral interaction and entry remained unclear. This paper aims to elucidate this mechanism, specifically investigating how amorphous nanostructures formed by unsaturated PAs facilitate virus-cell interactions.

Methods

The researchers employed a multi-pronged approach to characterize the peptide amphiphiles and their interactions:

  • Electron Microscopy (TEM and SEM): Transmission Electron Microscopy (TEM) and Scanning Electron Microscopy (SEM) were used to visualize the morphology of the peptide amphiphiles (both fibrillar pal-PA and amorphous eic-PA) and their interactions with virus-like particles (VLPs) and cells. This allowed for direct observation of structural differences and binding patterns.
  • Atomic Force Microscopy (AFM): AFM was utilized to provide high-resolution topographical information about the peptide amphiphile structures, particularly for the amorphous eic-PA, and to quantify aggregate sizes.
  • Confocal Fluorescence Microscopy: This technique was used to observe the colocalization of PAs with cells and VLPs in situ, providing insights into the spatial distribution and initial interaction dynamics over time.
  • Fluorescence Microscopy with Thioflavin-T staining: Used to confirm the presence of β-sheet structures within the peptide assemblies, a key characteristic of their self-assembly.
  • Virus-Like Particles (VLPs): Murine leukemia virus (MLV)-derived VLPs were used as a safe, non-infectious surrogate for retroviruses like HIV-1, allowing for the study of viral interaction mechanisms without the risks associated with infectious agents.

Datasets

Not discussed in the paper. The study relies on experimental data generated through microscopy and biochemical assays.

Key Insights and Ideas

  • Amorphous vs. Fibrillar Mechanism: The core insight is that unsaturated PAs, like eic-PA, form amorphous nanostructures that enhance viral entry through a mechanism distinct from fibrillar PAs. This challenges the prevailing view that ordered fibril formation is essential for transduction enhancement.
  • Direct Plasma Membrane Binding: Amorphous eic-PA structures facilitate direct binding of VLPs to the plasma membrane, bypassing the need for extensive engagement with cellular protrusions, which is characteristic of fibrillar PAs.
  • Increased Surface Area and Binding Sites: The amorphous nature of eic-PA leads to smaller aggregate sizes and a higher number of aggregates compared to fibrillar pal-PA. This provides a larger effective surface area and more accessible binding sites for VLPs and cells.
  • Molecular Flexibility and Disruption: The polyunsaturated fatty acid chain in eic-PA introduces kinks, disrupting dense packing and promoting structural disorder. This flexibility is key to forming the amorphous structures and enabling dynamic interactions.
  • Potential for Improved Delivery: The direct binding mechanism mediated by amorphous PAs is hypothesized to enhance VLP uptake and subsequent gene delivery, offering a more efficient route for therapeutic applications.

Key Results

  • Morphological Differences: TEM and SEM clearly demonstrated that pal-PA forms ordered, fibrillar aggregates, while eic-PA forms heterogeneous, amorphous structures ranging from nano- to micrometers.
  • Aggregate Size and Number: Micrometer-sized eic-PA aggregates had a median area of 1.0 µm², significantly smaller than pal-PA aggregates (3.3 µm²). Eic-PA also formed approximately 5 times more aggregates per unit area.
  • VLP-Cell Interaction: Confocal microscopy showed that both PAs colocalized with cells, but eic-PA aggregates were more evenly distributed and smaller. TEM and SEM confirmed VLPs binding to the surface of amorphous eic-PA aggregates and, crucially, directly to the plasma membrane.
  • Surface Modification: SEM images suggested that small eic-PA fragments might cover the surface of VLPs and filopodia, making them appear "less smooth" and facilitating interaction.

Limitations and Future Work

  • In Vitro Study: The current study was conducted in vitro using cell cultures and VLPs. Further in vivo studies are needed to validate these findings in a more complex biological system.
  • Mechanism Elucidation: While the direct binding mechanism is proposed, further detailed studies might be needed to fully dissect the molecular interactions at the VLP-PA-cell membrane interface.
  • Future Directions: The authors suggest exploring how different lipid-peptide combinations influence nanoscale structure and improve delivery outcomes across various cell types and cargos. Investigating the precise molecular interactions and optimizing amorphous PA designs for specific therapeutic applications are also promising avenues. The potential for these amorphous nanostructures in other therapeutic areas beyond gene delivery could also be explored.

Summary updated

Abstract

Peptide amphiphiles can form fibrillar and amorphous structures. While fibrillar assemblies have previously been shown to enhance viral infectivity or retroviral transduction for gene delivery, we now elucidate the mechanism behind amorphous peptide amphiphiles that promote virus-cell interactions. Using electron microscopy, we reveal that amorphous fragments of polyunsaturated peptide amphiphiles allow for more VLPs to bind directly to the plasma membrane, explaining previously observed efficient viral entry and superior biodegradation compared to state-of-the-art adjuvants. We believe our work highlights the potential of unsaturated fatty acid peptide hybrid materials for clinical applications.
BibTeX
@article{roche2025interactions,
  author = {Jean Roche and Lena Rauch‐Wirth and L Zimmerman and Fabian Zech and Jan Münch and Clarissa Read and Kübra Kaygisiz},
  title = {{Interactions of Peptide Amphiphiles With Viruses and Cells Are Enabled by Amorphous Nanostructures}},
  journal = {Journal of Peptide Science},
  year = {2025},
  doi = {10.1002/psc.70051},
}
Figure